{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:18:28Z","timestamp":1774462708398,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","award":["2018"],"award-info":[{"award-number":["2018"]}],"id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology","award":["17K08324"],"award-info":[{"award-number":["17K08324"]}]},{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology","award":["16K21501"],"award-info":[{"award-number":["16K21501"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12640-019-0007-7","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T02:03:27Z","timestamp":1549505007000},"page":"575-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mechanism Underlying Organophosphate Paraoxon-Induced Kinetic Tremor"],"prefix":"10.1007","volume":"35","author":[{"given":"Higor Alves","family":"Iha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofumi","family":"Kunisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misaki","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nami","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Hashimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-7135","authenticated-orcid":false,"given":"Yukihiro","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"7_CR1","first-page":"183","volume":"73","author":"HK Abrams","year":"1950","unstructured":"Abrams HK, Leonard AR (1950) Toxicology of organic phosphate insecticides. Calif Med 73:183\u2013186","journal-title":"Calif Med"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev.publhealth.25.101802.123020","volume":"25","author":"MC Alavanja","year":"2004","unstructured":"Alavanja MC, Hoppin JA, Kamel F (2004) Health effects of chronic pesticide exposure: cancer and neurotoxicity. Annu Rev Public Health 25:155\u2013197","journal-title":"Annu Rev Public Health"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1081\/CLT-120018273","volume":"41","author":"H Arima","year":"2003","unstructured":"Arima H, Sobue K, So M, Morishima T, Ando H, Katsuya H (2003) Transient and reversible parkinsonism after acute organophosphate poisoning. J Toxicol Clin Toxicol 41:67\u201370","journal-title":"J Toxicol Clin Toxicol"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuropharm.2005.01.015","volume":"48","author":"JF Bastlund","year":"2005","unstructured":"Bastlund JF, Berry D, Watson WP (2005) Pharmacological and histological characterisation of nicotine-kindled seizures in mice. Neuropharmacology 48:975\u2013983","journal-title":"Neuropharmacology"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/BF00237502","volume":"42","author":"C Batini","year":"1981","unstructured":"Batini C, Buisseret-Delmas C, Conrath-Verrier M (1981) Harmaline-induced tremor. I. Regional metabolic activity as revealed by [14C]2-deoxyglucose in cat. Exp Brain Res 42:371\u2013382","journal-title":"Exp Brain Res"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0006-8993(84)90139-2","volume":"322","author":"JF Bernard","year":"1984","unstructured":"Bernard JF, Buisseret-Delmas C, Laplante S (1984) Inferior olivary neurons: 3-acetylpyridine effects on glucose consumption, axonal transport, electrical activity and harmaline-induced tremor. Brain Res 322:382\u2013387","journal-title":"Brain Res"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.52.7.1467","volume":"52","author":"MH Bhatt","year":"1999","unstructured":"Bhatt MH, Elias MA, Mankodi AK (1999) Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases. Neurology 52:1467\u20131471","journal-title":"Neurology"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1476-5381.1997.tb06832.x","volume":"120","author":"DA Brown","year":"1997","unstructured":"Brown DA, Forward A, Marsh S, Caulfield MP (1997) Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br J Pharmacol 120:444\u2013446","journal-title":"Br J Pharmacol"},{"key":"7_CR9","first-page":"249","volume":"138","author":"AK Cho","year":"1962","unstructured":"Cho AK, Haslett WL, Jenden DJ (1962) The peripheral actions of oxotremorine, a metabolite of tremorine. J Pharmacol Exp Ther 138:249\u2013257","journal-title":"J Pharmacol Exp Ther"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.bcp.2013.06.023","volume":"86","author":"SF Colombo","year":"2013","unstructured":"Colombo SF, Mazzo F, Pistillo F, Gotti C (2013) Biogenesis, trafficking and up-regulation of nicotinic ACh receptors. Biochem Pharmacol 86:1063\u20131073","journal-title":"Biochem Pharmacol"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1523\/JNEUROSCI.02-08-01072.1982","volume":"2","author":"M Dam","year":"1982","unstructured":"Dam M, Wamsley JK, Rapoport SI, London ED (1982) Effects of oxotremorine on local glucose utilization in the rat cerebral cortex. J Neurosci 2:1072\u20131078","journal-title":"J Neurosci"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","volume":"47","author":"JA Dani","year":"2007","unstructured":"Dani JA, Bertrand D (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47:699\u2013729","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0006-8993(81)91100-8","volume":"226","author":"D Dow-Edwards","year":"1981","unstructured":"Dow-Edwards D, Dam M, Peterson JM, Rapoport SI, London ED (1981) Effect of oxotremorine on local cerebral glucose utilization in motor system regions of the rat brain. Brain Res 226:281\u2013289","journal-title":"Brain Res"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neuroscience.2014.05.040","volume":"282c","author":"P Faure","year":"2014","unstructured":"Faure P, Tolu S, Valverde S, Naude J (2014) Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity. Neuroscience 282c:86\u2013100","journal-title":"Neuroscience"},{"key":"7_CR15","volume-title":"The mouse brain in stereotaxic coordinates","author":"KBJ Franklin","year":"2008","unstructured":"Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates, 3rd edn. Academic Press, San Diego","edition":"3"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0091-3057(89)90280-3","volume":"34","author":"Y Gomita","year":"1989","unstructured":"Gomita Y, Suemaru K, Furuno K, Araki Y (1989) Nicotine-induced tail-tremor and drug effects. Pharmacol Biochem Behav 34:817\u2013821","journal-title":"Pharmacol Biochem Behav"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0091-3057(91)90579-Q","volume":"40","author":"Y Gomita","year":"1991","unstructured":"Gomita Y, Suemaru K, Furuno K, Araki Y (1991) Tail-tremor induced by exposure to cigarette smoke in rats. Pharmacol Biochem Behav 40:453\u2013455","journal-title":"Pharmacol Biochem Behav"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","volume":"27","author":"C Gotti","year":"2006","unstructured":"Gotti C, Zoli M, Clementi F (2006) Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 27:482\u2013491","journal-title":"Trends Pharmacol Sci"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0301-0082(96)00021-4","volume":"50","author":"DG Herrera","year":"1996","unstructured":"Herrera DG, Robertson HA (1996) Activation of c-fos in the brain. Prog Neurobiol 50:83\u2013107","journal-title":"Prog Neurobiol"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1046\/j.1365-2826.2002.00775.x","volume":"14","author":"GE Hoffman","year":"2002","unstructured":"Hoffman GE, Lyo D (2002) Anatomical markers of activity in neuroendocrine systems: are we all \u2018fos-ed out\u2019? J Neuroendocrinol 14:259\u2013268","journal-title":"J Neuroendocrinol"},{"key":"7_CR21","first-page":"389","volume-title":"In vivo neuropharmacology and neurophysiology","author":"HA Iha","year":"2016","unstructured":"Iha HA, Kunisawa N, Tokudome K, Mukai T, Kinboshi M, Shimizu S, Ohno Y (2016) Immunohistochemical analysis of Fos protein expression for exploring brain regions (foci) related to central nervous system (CNS) disorders and drug actions. In: Philippu A (ed) In vivo neuropharmacology and neurophysiology. Springer, New York, pp 389\u2013408"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fphar.2017.00057","volume":"8","author":"HA Iha","year":"2017","unstructured":"Iha HA, Kunisawa N, Shimizu S, Tokudome K, Mukai T, Kinboshi M, Ikeda A, Ito H, Serikawa T, Ohno Y (2017) Nicotine elicits convulsive seizures by activating amygdalar neurons. Front Pharmacol 8:57","journal-title":"Front Pharmacol"},{"key":"7_CR23","first-page":"139","volume":"43","author":"J Jeyaratnam","year":"1990","unstructured":"Jeyaratnam J (1990) Acute pesticide poisoning: a major global health problem. World Health Stat Q 43:139\u2013144","journal-title":"World Health Stat Q"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/taap.1993.1154","volume":"121","author":"E Kalistekorhonen","year":"1993","unstructured":"Kalistekorhonen E, Ylitalo P, Hanninen O, Raushel FM (1993) Phosphotriesterase decreases paraoxon toxicity in mice. Toxicol Appl Pharmacol 121:275\u2013278","journal-title":"Toxicol Appl Pharmacol"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0197-0186(98)00023-0","volume":"33","author":"KJ Kovacs","year":"1998","unstructured":"Kovacs KJ (1998) c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem Int 33:287\u2013297","journal-title":"Neurochem Int"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbr.2016.08.013","volume":"314","author":"N Kunisawa","year":"2016","unstructured":"Kunisawa N, Iha HA, Shimizu S, Tokudome K, Mukai T, Kinboshi M, Serikawa T, Ohno Y (2016) Nicotine evokes kinetic tremor by activating the inferior olive via alpha7 nicotinic acetylcholine receptors. Behav Brain Res 314:173\u2013180","journal-title":"Behav Brain Res"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jphs.2017.06.001","volume":"134","author":"N Kunisawa","year":"2017","unstructured":"Kunisawa N, Iha HA, Nomura Y, Onishi M, Matsubara N, Shimizu S, Ohno Y (2017) Serotonergic modulation of nicotine-induced kinetic tremor in mice. J Pharmacol Sci 134:131\u2013138","journal-title":"J Pharmacol Sci"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jphs.2018.05.007","volume":"137","author":"N Kunisawa","year":"2018","unstructured":"Kunisawa N, Shimizu S, Kato M, Iha HA, Iwai C, Hashimura M, Ogawa M, Kawaji S, Kawakita K, Abe K, Ohno Y (2018) Pharmacological characterization of nicotine-induced tremor: responses to anti-tremor and anti-epileptic agents. J Pharmacol Sci 137:162\u2013169","journal-title":"J Pharmacol Sci"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/0974-2700.130884","volume":"7","author":"OD Kwon","year":"2014","unstructured":"Kwon OD, Kim HK (2014) Parkinsonism as late sequela of organophosphate intoxication. J Emerg Trauma Shock 7:124\u2013125","journal-title":"J Emerg Trauma Shock"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuro.2015.07.006","volume":"50","author":"J Liu","year":"2015","unstructured":"Liu J, Parsons L, Pope C (2015) Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum. Neurotoxicology 50:20\u201327","journal-title":"Neurotoxicology"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jchemneu.2010.05.009","volume":"40","author":"R Machaalani","year":"2010","unstructured":"Machaalani R, Kashi PK, Waters KA (2010) Distribution of nicotinic acetylcholinereceptor subunits alpha7 and beta2 in the human brainstem and hippocampalformation. J Chem Neuroanat 40:223\u2013231","journal-title":"J Chem Neuroanat"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0014-2999(79)90446-1","volume":"56","author":"RT Matthews","year":"1979","unstructured":"Matthews RT, Chiou CY (1979) Effects of diethylcholine in two animal models of Parkinsonism tremors. Eur J Pharmacol 56:159\u2013162","journal-title":"Eur J Pharmacol"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF00999384","volume":"1","author":"AL Miller","year":"1986","unstructured":"Miller AL, Medina MA (1986) Cerebral metabolic effects of organophosphorus anticholinesterase compounds. Metab Brain Dis 1:147\u2013156","journal-title":"Metab Brain Dis"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tox.2007.10.024","volume":"244","author":"M Mohammadi","year":"2008","unstructured":"Mohammadi M, Ghani E, Ghasemi A, Khoshbaten A, Asgari A (2008) Synaptosomal GABA uptake decreases in paraoxon-treated rat brain. Toxicology 244:42\u201348","journal-title":"Toxicology"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1126\/science.3037702","volume":"237","author":"JI Morgan","year":"1987","unstructured":"Morgan JI, Cohen DR, Hempstead JL, Curran T (1987) Mapping patterns of c-fos expression in the central nervous system after seizure. Science (New York, NY) 237:192\u2013197","journal-title":"Science (New York, NY)"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0006-8993(78)91012-0","volume":"157","author":"SR Nelson","year":"1978","unstructured":"Nelson SR, Doull J, Tockman BA, Cristiano PJ, Samson FE (1978) Regional brain metabolism changes induced by acetylcholinesterase inhibitors. Brain Res 157:186\u2013190","journal-title":"Brain Res"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.neuropharm.2008.06.005","volume":"55","author":"Y Ohno","year":"2008","unstructured":"Ohno Y, Shimizu S, Imaki J, Ishihara S, Sofue N, Sasa M, Kawai Y (2008) Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens. Neuropharmacology 55:717\u2013723","journal-title":"Neuropharmacology"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.eplepsyres.2009.07.012","volume":"87","author":"Y Ohno","year":"2009","unstructured":"Ohno Y, Shimizu S, Harada Y, Morishita M, Ishihara S, Kumafuji K, Sasa M, Serikawa T (2009a) Regional expression of Fos-like immunoreactivity following seizures in Noda epileptic rat (NER). Epilepsy Res 87:70\u201376","journal-title":"Epilepsy Res"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1254\/jphs.08313FP","volume":"109","author":"Y Ohno","year":"2009","unstructured":"Ohno Y, Shimizu S, Imaki J (2009b) Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice. J Pharmacol Sci 109:593\u2013599","journal-title":"J Pharmacol Sci"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.nbd.2010.09.013","volume":"41","author":"Y Ohno","year":"2011","unstructured":"Ohno Y, Ishihara S, Mashimo T, Sofue N, Shimizu S, Imaoku T, Tsurumi T, Sasa M, Serikawa T (2011) Scn1a missense mutation causes limbic hyperexcitability and vulnerability to experimental febrile seizures. Neurobiol Dis 41:261\u2013269","journal-title":"Neurobiol Dis"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neuropharm.2012.04.031","volume":"63","author":"Y Ohno","year":"2012","unstructured":"Ohno Y, Okano M, Masui A, Imaki J, Egawa M, Yoshihara C, Tatara A, Mizuguchi Y, Sasa M, Shimizu S (2012) Region-specific elevation of D1 receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit\/hyperactivity disorder. Neuropharmacology 63:547\u2013554","journal-title":"Neuropharmacology"},{"key":"7_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123529","volume":"10","author":"Y Ohno","year":"2015","unstructured":"Ohno Y, Shimizu S, Tatara A, Imaoku T, Ishii T, Sasa M, Serikawa T, Kuramoto T (2015a) Hcn1 is a tremorgenic genetic component in a rat model of essential tremor. PLoS One 10:e0123529","journal-title":"PLoS One"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pneurobio.2015.09.005","volume":"134","author":"Y Ohno","year":"2015","unstructured":"Ohno Y, Shimizu S, Tokudome K, Kunisawa N, Sasa M (2015b) New insight into the therapeutic role of the serotonergic system in Parkinson\u2019s disease. Prog Neurobiol 134:104\u2013121","journal-title":"Prog Neurobiol"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neures.2010.12.007","volume":"69","author":"H Okuno","year":"2011","unstructured":"Okuno H (2011) Regulation and function of immediate-early genes in the brain: beyond neuronal activity markers. Neurosci Res 69:175\u2013186","journal-title":"Neurosci Res"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/15563650.2015.1126841","volume":"54","author":"KK Reji","year":"2016","unstructured":"Reji KK, Mathew V, Zachariah A, Patil AK, Hansdak SG, Ralph R, Peter JV (2016) Extrapyramidal effects of acute organophosphate poisoning. Clin Toxicol (Phila) 54:259\u2013265","journal-title":"Clin Toxicol (Phila)"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/0272-0590(84)90150-7","volume":"4","author":"FE Samson","year":"1984","unstructured":"Samson FE, Pazdernik TL, Cross RS, Giesler MP, Mewes K, Nelson SR, McDonough JH (1984) Soman induced changes in brain regional glucose use. Fundam Appl Toxicol 4:S173\u2013S183","journal-title":"Fundam Appl Toxicol"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/1531-8257(199903)14:2<252::AID-MDS1009>3.0.CO;2-N","volume":"14","author":"A Schrag","year":"1999","unstructured":"Schrag A, Schelosky L, Scholz U, Poewe W (1999) Reduction of Parkinsonian signs in patients with Parkinson\u2019s disease by dopaminergic versus anticholinergic single-dose challenges. Mov Disord 14:252\u2013255","journal-title":"Mov Disord"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1523\/JNEUROSCI.0476-14.2014","volume":"34","author":"PY Shih","year":"2014","unstructured":"Shih PY, Engle SE, Oh G, Deshpande P, Puskar NL, Lester HA, Drenan RM (2014) Differential expression and function of nicotinic acetylcholine receptors insubdivisions of medial habenula. J Neurosci 34:9789\u20139802","journal-title":"J Neurosci"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jphs.2015.03.004","volume":"127","author":"S Shimizu","year":"2015","unstructured":"Shimizu S, Mizuguchi Y, Sobue A, Fujiwara M, Morimoto T, Ohno Y (2015) Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice. J Pharmacol Sci 127:439\u2013445","journal-title":"J Pharmacol Sci"},{"key":"7_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071416","volume":"18","author":"S Shimizu","year":"2017","unstructured":"Shimizu S, Sogabe S, Yanagisako R, Inada A, Yamanaka M, Iha HA, Ohno Y (2017) Glycine-binding site stimulants of NMDA receptors alleviate extrapyramidal motor disorders by activating the nigrostriatal dopaminergic pathway. Int J Mol Sci 18:E1416","journal-title":"Int J Mol Sci"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.tox.2014.05.010","volume":"323","author":"S Shrot","year":"2014","unstructured":"Shrot S, Ramaty E, Biala Y, Bar-Klein G, Daninos M, Kamintsky L, Makarovsky I, Statlender L, Rosman Y, Krivoy A, Lavon O, Kassirer M, Friedman A, Yaari Y (2014) Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment. Toxicology 323:19\u201325","journal-title":"Toxicology"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pbb.2015.09.003","volume":"138","author":"A Tatara","year":"2015","unstructured":"Tatara A, Shimizu S, Masui A, Tamura M, Minamimoto S, Mizuguchi Y, Ochiai M, Mizobe Y, Ohno Y (2015) Atypical antipsychotic properties of AD-6048, a primary metabolite of blonanserin. Pharmacol Biochem Behav 138:14\u201319","journal-title":"Pharmacol Biochem Behav"},{"key":"7_CR53","first-page":"91","volume":"82","author":"JH Thompson","year":"1955","unstructured":"Thompson JH (1955) Cholinesterase inhibiting insecticides (parathion): chemical and clinical aspects. Calif Med 82:91\u201395","journal-title":"Calif Med"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0024-3205(84)90249-2","volume":"35","author":"J Wess","year":"1984","unstructured":"Wess J, Lambrecht G, Moser U, Mutschler E (1984) A comparison of the antimuscarinic effects of pirenzepine and N-methylatropine on ganglionic and vascular muscarinic receptors in the rat. Life Sci 35:553\u2013560","journal-title":"Life Sci"},{"key":"7_CR55","first-page":"681","volume":"98","author":"F Yelamos","year":"1992","unstructured":"Yelamos F, Diez F, Martin C, Blanco JL, Garcia MJ, Lardelli A, Pena JF (1992) Acute organophosphate insecticide poisonings in the province of Almeria. A study of 187 cases. Med Clin (Barc) 98:681\u2013684","journal-title":"Med Clin (Barc)"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-0007-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-0007-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-0007-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T19:28:14Z","timestamp":1581017294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-0007-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-0007-7","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"15 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocols were approved by the Experimental Animal Research Committee at the Osaka University of Pharmaceutical Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}